Chinese venture capital firms Frontline BioVentures and WuXi Healthcare Ventures have agreed to merge to form a healthcare investment group named 6 Dimensions Capital, which will have combined assets under management (AUM) of RMB 5.5 billion ($800 million).
The new entity, which is likely to be one of the largest healthcare-focused investment firms, will also start raising new RMB and USD-denominated funds in the near future, according to an official statement.
